No Data
The Recent Pullback Must Have Dismayed SonoScape Medical Corp. (SZSE:300633) Insiders Who Own 55% of the Company
Are SonoScape Medical Corp. (SZSE:300633) Investors Paying Above The Intrinsic Value?
Earnings Miss: SonoScape Medical Corp. Missed EPS And Analysts Are Revising Their Forecasts
Why Investors Shouldn't Be Surprised By SonoScape Medical Corp.'s (SZSE:300633) 34% Share Price Surge
Open Healthcare: Report for the third quarter of 2024
Sonoscape Medical Corp. (300633.SZ): net income of 0.109 billion yuan in the first three quarters, a year-on-year decrease of 66.01%.
Gelonghui October 25th | Sonoscape Medical Corp. (300633.SZ) released the third quarter report for 2024, with the company achieving revenue of 1.398 billion yuan in the first three quarters, a decrease of 4.74% year-on-year; net income attributable to shareholders of the listed company was 0.109 billion yuan, a decrease of 66.01% year-on-year; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 86.1162 million yuan, a decrease of 73.21% year-on-year; basic earnings per share were 0.2520 yuan.
Risks To Shareholder Returns Are Elevated At These Prices For SonoScape Medical Corp. (SZSE:300633)
